375 related articles for article (PubMed ID: 23562186)
1. Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protects against ischemia/reperfusion-induced acute kidney injury.
Tsuda H; Yamahara K; Otani K; Okumi M; Yazawa K; Kaimori JY; Taguchi A; Kangawa K; Ikeda T; Takahara S; Isaka Y
Cell Transplant; 2014; 23(7):889-99. PubMed ID: 23562186
[TBL] [Abstract][Full Text] [Related]
2. Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis.
Tsuda H; Yamahara K; Ishikane S; Otani K; Nakamura A; Sawai K; Ichimaru N; Sada M; Taguchi A; Hosoda H; Tsuji M; Kawachi H; Horio M; Isaka Y; Kangawa K; Takahara S; Ikeda T
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1004-13. PubMed ID: 20739390
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
Zhuo W; Liao L; Fu Y; Xu T; Wu W; Yang S; Tan J
Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785
[TBL] [Abstract][Full Text] [Related]
4. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
[TBL] [Abstract][Full Text] [Related]
5. Use of mesenchymal stem cells and darbepoetin improve ischemia-induced acute kidney injury outcomes.
Altun B; Yilmaz R; Aki T; Akoglu H; Zeybek D; Piskinpasa S; Uckan D; Purali N; Korkusuz P; Turgan C
Am J Nephrol; 2012; 35(6):531-9. PubMed ID: 22653289
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats.
Ishikane S; Yamahara K; Sada M; Harada K; Kodama M; Ishibashi-Ueda H; Hayakawa K; Mishima K; Iwasaki K; Fujiwara M; Kangawa K; Ikeda T
J Mol Cell Cardiol; 2010 Nov; 49(5):753-61. PubMed ID: 20692268
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
8. Fetal mesenchymal stem cells ameliorate acute lung injury in a rat cardiopulmonary bypass model.
Taki T; Masumoto H; Funamoto M; Minakata K; Yamazaki K; Ikeda T; Sakata R
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):726-734. PubMed ID: 27838010
[TBL] [Abstract][Full Text] [Related]
9. Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice.
Jang HR; Park JH; Kwon GY; Lee JE; Huh W; Jin HJ; Choi SJ; Oh W; Oh HY; Kim YG
Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1149-61. PubMed ID: 25143451
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice.
Luo CJ; Zhang FJ; Zhang L; Geng YQ; Li QG; Hong Q; Fu B; Zhu F; Cui SY; Feng Z; Sun XF; Chen XM
Shock; 2014 Feb; 41(2):123-9. PubMed ID: 24169208
[TBL] [Abstract][Full Text] [Related]
11. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.
Du T; Cheng J; Zhong L; Zhao XF; Zhu J; Zhu YJ; Liu GH
Cytotherapy; 2012 Nov; 14(10):1215-27. PubMed ID: 22920838
[TBL] [Abstract][Full Text] [Related]
12. Protection of mesenchymal stem cells on acute kidney injury.
Zhao JJ; Liu JL; Liu L; Jia HY
Mol Med Rep; 2014 Jan; 9(1):91-6. PubMed ID: 24220681
[TBL] [Abstract][Full Text] [Related]
13. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.
Alfarano C; Roubeix C; Chaaya R; Ceccaldi C; Calise D; Mias C; Cussac D; Bascands JL; Parini A
Cell Transplant; 2012; 21(9):2009-19. PubMed ID: 22525800
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats.
Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T
Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174
[TBL] [Abstract][Full Text] [Related]
15. Stem cells from foreign body granulation tissue accelerate recovery from acute kidney injury.
Patel J; Pancholi N; Gudehithlu KP; Sethupathi P; Hart PD; Dunea G; Arruda JA; Singh AK
Nephrol Dial Transplant; 2012 May; 27(5):1780-6. PubMed ID: 22036939
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin improves survival of implanted stem cells in a rat model of renal ischemia-reperfusion injury.
Cai J; Yu X; Zhang B; Zhang H; Fang Y; Liu S; Liu T; Ding X
Am J Nephrol; 2014; 39(6):466-75. PubMed ID: 24854145
[TBL] [Abstract][Full Text] [Related]
17. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
[TBL] [Abstract][Full Text] [Related]
18. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury.
Ranghino A; Bruno S; Bussolati B; Moggio A; Dimuccio V; Tapparo M; Biancone L; Gontero P; Frea B; Camussi G
Stem Cell Res Ther; 2017 Feb; 8(1):24. PubMed ID: 28173878
[TBL] [Abstract][Full Text] [Related]
19. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
[TBL] [Abstract][Full Text] [Related]
20. Impact of ex vivo administration of mesenchymal stem cells on the function of kidney grafts from cardiac death donors in rat.
Iwai S; Sakonju I; Okano S; Teratani T; Kasahara N; Yokote S; Yokoo T; Kobayash E
Transplant Proc; 2014 Jun; 46(5):1578-84. PubMed ID: 24935331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
